GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (CHIX:SANp) » Definitions » Dividend Payout Ratio

Sanofi (CHIX:SANP) Dividend Payout Ratio : 1.36 (As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sanofi Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Sanofi's Dividend Payout Ratio for the months ended in Jun. 2024 was 1.36.

The historical rank and industry rank for Sanofi's Dividend Payout Ratio or its related term are showing as below:

CHIX:SANp' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.45   Med: 0.61   Max: 0.82
Current: 0.68


During the past 13 years, the highest Dividend Payout Ratio of Sanofi was 0.82. The lowest was 0.45. And the median was 0.61.

CHIX:SANp's Dividend Payout Ratio is ranked worse than
82.37% of 431 companies
in the Drug Manufacturers industry
Industry Median: 0.37 vs CHIX:SANp: 0.68

As of today (2024-12-15), the Dividend Yield % of Sanofi is 4.20%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Sanofi was 4.70%. The lowest was 2.84%. And the median was 3.71%.

Sanofi's Dividends per Share for the months ended in Jun. 2024 was €3.76.

During the past 12 months, Sanofi's average Dividends Per Share Growth Rate was 5.60% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 4.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 3.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 2.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sanofi was 37.90% per year. The lowest was -15.60% per year. And the median was 4.55% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Sanofi Dividend Payout Ratio Historical Data

The historical data trend for Sanofi's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Dividend Payout Ratio Chart

Sanofi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 0.57 0.57 0.45 0.60

Sanofi Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.02 - 1.12 - 1.36

Competitive Comparison of Sanofi's Dividend Payout Ratio

For the Drug Manufacturers - General subindustry, Sanofi's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Sanofi's Dividend Payout Ratio falls into.



Sanofi Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Sanofi's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=3.56/ 5.906
=0.60

Sanofi's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=3.76/ 2.762
=1.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanofi (CHIX:SANp) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Sanofi Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Sanofi's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi Business Description

Address
46, avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.